Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis.
Schepers M, Paes D, Tiane A, Rombaut B, Piccart E, van Veggel L, Gervois P, Wolfs E, Lambrichts I, Brullo C, Bruno O, Fedele E, Ricciarelli R, Ffrench-Constant C, Bechler ME, van Schaik P, Baron W, Lefevere E, Wasner K, Grünewald A, Verfaillie C, Baeten P, Broux B, Wieringa P, Hellings N, Prickaerts J, Vanmierlo T. Schepers M, et al. Among authors: brullo c. Brain Behav Immun. 2023 Mar;109:1-22. doi: 10.1016/j.bbi.2022.12.020. Epub 2022 Dec 28. Brain Behav Immun. 2023. PMID: 36584795 Free article.
An Update on JAK Inhibitors.
Musumeci F, Greco C, Giacchello I, Fallacara AL, Ibrahim MM, Grossi G, Brullo C, Schenone S. Musumeci F, et al. Among authors: brullo c. Curr Med Chem. 2019;26(10):1806-1832. doi: 10.2174/0929867325666180327093502. Curr Med Chem. 2019. PMID: 29589523 Review.
Bcr-Abl tyrosine kinase inhibitors: a patent review.
Desogus A, Schenone S, Brullo C, Tintori C, Musumeci F. Desogus A, et al. Among authors: brullo c. Expert Opin Ther Pat. 2015 Apr;25(4):397-412. doi: 10.1517/13543776.2015.1012155. Epub 2015 Feb 6. Expert Opin Ther Pat. 2015. PMID: 25656651 Review.
Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma.
Tintori C, Fallacara AL, Radi M, Zamperini C, Dreassi E, Crespan E, Maga G, Schenone S, Musumeci F, Brullo C, Richters A, Gasparrini F, Angelucci A, Festuccia C, Delle Monache S, Rauh D, Botta M. Tintori C, et al. Among authors: brullo c. J Med Chem. 2015 Jan 8;58(1):347-61. doi: 10.1021/jm5013159. Epub 2014 Dec 3. J Med Chem. 2015. PMID: 25469771
Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative.
Morretta E, Brullo C, Belvedere R, Petrella A, Spallarossa A, Monti MC. Morretta E, et al. Among authors: brullo c. Int J Mol Sci. 2023 May 24;24(11):9200. doi: 10.3390/ijms24119200. Int J Mol Sci. 2023. PMID: 37298148 Free PMC article.
115 results